Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Kyowa Hakko Kirin to sell Leo Pharma's psoriasis treatment in Japan

Executive Summary

Kyowa Hakko Kirin Co. Ltd. licensed Japanese co-promotion and distribution rights to dermatology-focused Leo Pharma KK’s (a division of Leo Pharma AS) topical calcipotriol/betamethasone dipropionate combination therapy for psoriasis vulgaris.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Co-Promotion

Related Companies

Advertisement
UsernamePublicRestriction

Register